Peptide encyclopedia

NNMT inhibition in preclinical adipose models can change NAD+/SAM handling. That is not a proven basal-metabolic-rate doubling in humans.

Negative regulator of pluripotent hematopoietic stem-cell proliferation in classical work; antifibrotic signaling appears in organ-fibrosis models. ACE inhibitors raise endogenous Ac-SDKP — that pharmacology is not a reason to inject a research vial as a fibrosis drug.

Adamantane is used on other peptides to increase lipophilicity and metabolic stability. That is a medicinal-chemistry rationale, not demonstrated Semax-receptor PK for this conjugate.

AHK-Cu is studied as a hair-follicle and extracellular-matrix signal in dermal models, overlapping GHK-Cu’s copper-delivery and collagen-related gene effects. It is not a substitute for minoxidil or a prescription hair drug.

C-terminal GH fragment analog studied for lipolytic signaling without the full GH endocrine package. Failed late-stage obesity work is part of the file. Not Egrifta VAT math.

Operating precisely at the dermal neuromuscular junction, Argireline acts as a direct structural decoy. It meticulously mimics the N-terminal end of the SNAP-25 protein, aggressively competing for space during the assembly of the SNARE protein complex (combining with syntaxin and VAMP). By destabilizing this complex, it violently restricts the docking of vesicles and throttles the release of acetylcholine, plunging the target muscle fibers into a state of smooth, prolonged relaxation.

B7-33 retains RXFP1 signaling with a simpler chain than two-chain H2 relaxin. Preclinical anti-fibrotic and vascular work exists. Gray-market vials are not that program.

Bypassing systemic circulation, Bonothyrk’s precise peptide fractions enter the nuclei of the parathyroid chief cells. Serving as an absolute epigenetic governor, it forcefully recalibrates the silenced genes responsible for the synthesis and precise pulsatile secretion of Parathyroid Hormone (PTH). This flawless, youth-level PTH regulation orchestrates the perfect physiological balance of calcium and phosphorus absorption across the gut, kidneys, and bone matrices.

Functioning as a targeted neurological switch, Bremelanotide bypasses peripheral vascular mechanics and strikes directly at the Melanocortin-4 Receptors (MC4R) embedded within the hypothalamus and limbic system. This activates deep, primal arousal pathways, converting psychological desire into physical response. However, it concurrently agonizes MC4R receptors located in the brainstem’s area postrema, routinely triggering distinct, transient nausea as a primary physiological side effect.

Navigating directly to bronchial epithelial tissue, Bronchogen slips into cell nuclei to operate as a specialized transcription factor. It aggressively modulates the genetic cascades dictating mucin production, ciliary motion, and localized inflammatory responses. By forcefully downregulating destructive pro-inflammatory cytokines while simultaneously restoring optimal ciliary sweeping action, it rapidly halts chronic lung degradation and catalyzes sweeping alveolar regeneration.

Long-acting amylin analog at AMYR (CALCR+RAMPs). Area postrema satiety and gastric emptying, complementary to GLP-1 in CagriSema trials.

Cardiogen infiltrates the highly demanding environment of cardiac myocytes, binding directly to regulatory DNA sequences. It executes a profound epigenetic overhaul by upregulating the synthesis of critical contractile proteins (like actin and myosin) and forcing massive mitochondrial biogenesis within the heart muscle. Simultaneously, it triggers hyper-potent anti-apoptotic pathways, ruthlessly preventing cardiac cell death under severe ischemic or oxidative stress.

Low-molecular-weight porcine brain hydrolysate. Mixture identity. Not a single CAS sequence you can verify like BPC-157.

Competitive GnRH-receptor antagonist: immediate LH/FSH suppression without the flare of GnRH agonists. Linear SC kinetics in the labeled 0.25–3 mg range.

Operating via the principle of exact tissue-matching, Chitomur's organ-specific peptide fractions migrate to the bladder and penetrate both the smooth muscle (detrusor) and the urothelium. Once inside the nucleus, they trigger an immense epigenetic reactivation of youthful structural genes. This forcefully ramps up the synthesis of fresh collagen and elastin within the bladder wall, restoring powerful contractility and fundamentally eliminating age-related urinary dysfunction.

Tetrasubstituted GRF(1-29) lasts longer than native GHRH because of DPP-4-resistant substitutions, not because of albumin DAC. Pulse is minutes-class. PMID 16352683 on older catalog cards is the DAC paper; do not paste it as Mod GRF PK.

A 30-amino acid synthetic GHRH analog modified with a maleimidopropionic acid complex (DAC). This complex covalently bonds directly to human serum albumin (Cys34), artificially extending the peptide's half-life to roughly 8 days. Unlike physiological pulsation, DAC induces a persistent "GH bleed" - a continuous, relentless agonism of pituitary somatotrophs, establishing drastically elevated IGF-1 troughs while bypassing the strict constraints of somatostatin signaling.

By delivering hundreds of low-molecular-weight (<10 kDa) neuropeptides across the blood-brain barrier, Cortexin exerts a total, overarching neuromodulatory effect. It aggressively throttles lethal glutamate excitotoxicity, which destroys neurons post-injury. Simultaneously, it exerts profound neurotrophic actions mimicking both BDNF and NGF, physically forcing the repair of axonal membranes, promoting massive synaptic plasticity, and forcefully correcting localized GABAergic/glutamatergic imbalances.

Desmopressin acts as a hyper-selective agonist exclusively targeting the V2 receptors located deep within the renal collecting ducts. Upon activation, it forces a massive, immediate translocation of Aquaporin-2 water channels to the apical membrane, brutally locking down free water excretion and driving intense fluid reabsorption. Secondarily, it forces endothelial cells to dump massive reserves of von Willebrand factor (vWF) and Factor VIII into the bloodstream, triggering rapid hemostasis.

Historical neuromodulator papers around NREM architecture and HPA. Short t½ is why bedtime shots are folklore, not a depot hypnotic.

Selective amylin-pathway agonism in a Lilly long-acting construct. Obesity and metabolic programs are sponsor-owned; gray-market fill is not that material.

Endoluten targets the absolute apex of the endocrine hierarchy: the pinealocyte. Escorting organ-specific epigenetic regulators directly into the pineal gland, it forcefully binds to the DNA regions governing melatonin production. By radically upregulating transcription of rate-limiting enzymes like AANAT, it restores youthful, massive surges of endogenous melatonin, which in turn acts as a systemic cascade trigger to reset the entire neuroendocrine system and halt telomere degradation.

Containing a massive, full-spectrum matrix of pineal nucleoproteins (including naturally occurring Ala-Glu-Asp-Gly), Epithalamin executes total epigenetic domination. Slipping into pinealocytes, it violently un-silences the promoter regions for the AANAT enzyme, restoring massive, youthful melatonin synthesis. Concurrently, it penetrates systemic somatic cells to activate Telomerase, forcing the physical elongation of chromosomal telomeres and actively defying the Hayflick limit of cellular division.

FGL is a 15-aa sequence from NCAM that can interact with FGF receptors in published neural-plasticity work. Community “nootropic stack” use is off that literature.

Operates as a high-affinity binding protein. Follistatin 344 aggressively intercepts, binds to, and permanently neutralizes TGF-beta family ligands - specifically Myostatin (GDF-8) and Activin - before they can successfully dock with the Activin type IIB receptor (ActRIIB) on muscle tissue. By physically blockading this negative feedback loop, the intracellular SMAD signaling cascade is silenced. Consequently, satellite cells are released from their dormant state, proliferating violently and fusing into massive new muscle fibers unencumbered by natural genetic growth brakes.

GHK is an endogenous matricryptic tripeptide. Copper-free material can still bind ambient copper in tissue; that is chemistry, not proof that a Basic SKU equals Pickart’s GHK-Cu dataset.

Functioning as a master metabolic and endocrine switch, Ghrelin actively crosses the blood-brain barrier to violently agonize GHS-R1a receptors localized in the hypothalamic arcuate nucleus. This triggers NPY and AgRP neurons to forcefully stimulate a voracious appetite. Simultaneously, it strikes the anterior pituitary to unleash a massive dumping of stored Growth Hormone, while independent vagal nerve activation drives profound systemic anti-inflammatory responses and deep cardiovascular protection.

GHS-R1a hexapeptide. GH pulse plus ghrelin-pathway appetite, with cortisol and prolactin elevation versus ipamorelin.

Three research SKUs in one bottle. GHK-Cu is a copper tripeptide. BPC-157 is a 15-mer. TB-500 as sold is usually Ac-LKKTETQ, not full thymosin β4. Complementary marketing is not a combination trial.

Operates as a direct agonist at the GnRH receptor in the anterior pituitary gland. To remain effective, Gonadorelin MUST be administered in sharp, intermittent pulses to mimic natural hypothalamic bursts. This pulsatile rhythm prevents receptor downregulation, forcing the pituitary to continuously pump immense volumes of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) into the bloodstream. These gonadotropins subsequently surge the testes, aggressively stimulating Leydig cells to manufacture testosterone and Sertoli cells to sustain spermatogenesis.

No single mechanism. Kit of Cytomax organ complexes. Not estradiol.

hCG binds LH/hCG receptors on testicular Leydig cells (testosterone) and ovarian theca/luteal cells (ovulation and luteal support). Urinary products are calibrated in USP/IU; do not convert IU to milligrams without the product’s stated specific activity.

C-terminal GH snippet studied for lipolytic signaling. Do not launder full GH or tesamorelin VAT percentages onto this fragment.

Operates both intracellularly and extracellularly through dual neuroprotective pathways. Extracellularly, it binds forcefully to a complex consisting of CNTFR/WSX-1/gp130, activating the formidable neuro-preservation STAT3 signaling cascade. Intracellularly, Humanin specifically intercepts and aggressively binds to the pro-apoptotic protein BAX (Bcl-2-associated X protein). By neutralizing BAX, it physically prevents the devastating release of cytochrome c from the mitochondria, abruptly halting the cellular execution sequence before the neuron can die.

Truncation at residues 1–3 reduces IGFBP sequestration so more peptide is free to agonize IGF1R (PI3K/AKT/mTOR). The short half-life is why community use is local rather than systemic. Hypoglycemia risk is real - same receptor family as insulin.

Operates as a highly selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR-1a). Unlike GHRP-6 or GHRP-2, Ipamorelin's molecular structure is entirely devoid of the lipogenic or adrenocorticotropic side effects; it forcefully stimulates the pituitary to release a steady, prolonged pulse of GH without simultaneously triggering the adverse downstream release of cortisol, aldosterone, or prolactin.

Functions as the exclusive agonist for the KISS1R (GPR54) receptor located precisely on the GnRH-secreting neurons within the hypothalamus. Upon binding, Kisspeptin violently depolarizes these neurons, forcing an overwhelmingly strong, massive surge of endogenous Gonadotropin-Releasing Hormone (GnRH). This upstream cascade inherently triggers a perfectly balanced, pulsatile release of LH and FSH from the pituitary, orchestrating dramatic downstream intra-testicular testosterone synthesis and robust spermatogenesis without disrupting the body's natural homeostatic rhythms.

Adds KPV (α-MSH fragment) to GHK-Cu + BPC-157 + TB-500 7-mer. Each leaf has its own honesty file. The bottle does not inherit all four literatures.

Instead of directly agonizing massive systemic opioid receptors, Kyotorphin binds to its own highly specific Gi-protein-coupled receptor. This triggers a massive, localized synaptic release of endogenous Met-enkephalin. Concurrently, Kyotorphin violently blocks DPP-III (the enzyme that destroys enkephalins), heavily dampens excitotoxic NMDA receptor activity, and physically interferes with the pathogenic aggregation of amyloid-β plaques within brain tissue.

Existing as an incredibly dense, amphipathic β-hairpin loop carrying a massive (+8) positive charge, Lactoferricin B executes a devastating electrostatic assault. It violently binds to the negatively charged lipopolysaccharides (LPS) of Gram-negative bacteria, physically shattering their membrane integrity and inducing explosive lysis. Beyond bacteria, it is capable of penetrating the membranes of specific cancer cells, directly triggering catastrophic mitochondrial depolarization and forcing immediate cellular apoptosis.

Marketed as modulating acetylcholine release at expression muscles via an enkephalin-like motif. Evidence is cosmetic/in vitro, not a drug program. SNARE-targeting hexapeptides (Argireline/SNAP-8) are a different mechanism.

Acting strictly on the prostatic cellular level, Libidon delivers tissue-specific peptide fractions directly into the nucleus of human prostate epithelial cells. By forcefully modulating localized gene expression, it disrupts the abnormal, accelerated cellular proliferation responsible for prostate enlargement. This targeted epigenetic oversight re-establishes normal, restricted glandular function and dramatically reduces localized pro-inflammatory signaling, allowing the prostate to physically normalize its own architecture.

Livagen executes a highly disruptive epigenetic mechanism. As humans age, critical protective genes become tightly wound into inaccessible clusters called heterochromatin, silencing them permanently. Livagen physically inserts itself into the DNA structure of aging hepatocytes (liver cells) and lymphocytes, violently decondensing (unwinding) these pericentromeric heterochromatin regions. This action forcefully reactivates silenced ribosomal genes, instigating massive de novo synthesis of foundational detoxification enzymes and accelerating absolute hepatic tissue regeneration.

Because LL-37 is highly amphipathic (carrying both hydrophilic and lipophilic properties), it effortlessly binds to and disintegrates the lipid membranes of offending bacteria, fungi, and enveloped viruses via catastrophic pore formation. Simultaneously, it engages formyl peptide receptor-like 1 (FPRL1) and modulates Toll-like receptor (TLR) signaling, deploying a highly coordinated swarm of neutrophils and macrophages to infection sites while aggressively suppressing pro-inflammatory cytokine storms.

Oral ghrelin-mimetic peptidomimetic. Labeled use is a single AGHD stimulation test, not chronic GH optimization.

Matrixyl’s core KTTKS pentapeptide perfectly mimics a sheared collagen fragment, acting as a false alarm that violently triggers the skin’s wound-healing cascade. Outfitted with a palmitoyl lipid tail to ruthlessly penetrate the stratum corneum, it descends into the dermis and locks into integrin receptors on resting fibroblasts. This forces an immediate, rampant upregulation in the synthesis of structural Collagen I, III, IV, and vital extracellular matrix glycosaminoglycans.

MT-1 operates as a highly selective, sniper-like agonist exclusively targeting the Melanocortin-1 Receptor (MC1R) located directly on the surface of epidermal melanocytes. By completely bypassing the MC3R and MC4R receptors, MT-1 forces massive eumelanin synthesis and skin darkening entirely without triggering the intense libido spikes, spontaneous erections, or severe appetite suppression notoriously caused by the off-target receptor bleeding seen in Melanotan II.

Upon precise local injection, MGF immediately saturates the extracellular space of the damaged tissue. Rather than inducing standard protein synthesis, it acts strictly as an extreme mitogenic trigger. It forces the local activation and hyper-proliferation of reserve satellite cells (muscle stem cells) at the exact site of injury. These rapidly dividing new nuclei ultimately fuse to existing muscle fibers, permanently increasing the muscle's cross-sectional growth potential long after the peptide has degraded.

mtDNA-encoded 16-mer reported to act as a retrograde metabolic signal, including AMPK-linked glucose uptake in preclinical models. Folate-cycle / AICAR language is the paper mechanism, not a human indication.

Parent AEDG is a pineal tetrapeptide studied for telomerase/pineal claims. Acetyl + amide slow exopeptidases in principle. That is analog chemistry, not a second clinical program.

N-acetylation reduces aminopeptidase attack on the ACTH 4–10 core. Downstream claims (BDNF, attention) are inherited from Semax papers, not from a dedicated NAS dataset.

Electron shuttle and substrate for sirtuins/PARPs in textbooks. Exogenous NAD+ pharmacokinetics are not a guarantee of nuclear SIRT1 activation as a clinical endpoint.

Preclinical work (Ostrovskaya 2008; Vakhitova 2016) reports hippocampal NGF/BDNF mRNA changes and selective HIF-1 reporter activation. Short parent exposure is why people do not treat it like a weekly GH peptide.

Agonizes somatostatin receptors (mainly sst2/sst5), suppressing GH, insulin, glucagon, and various gut peptides. Plasma t½ ~1.8 hours versus 1–3 minutes for native somatostatin.

Non-peptide oral GLP-1R agonist. Survives the gut without SNAC. Not Rybelsus (oral semaglutide).

Functions as a potent agonist at specific G-protein coupled oxytocin receptors heavily concentrated in the amygdala and ventromedial hypothalamus. Upon binding, it profoundly suppresses the hyper-reactivity of the amygdala - the brain's critical fear center - thereby actively blunting the release of Corticotropin-Releasing Hormone (CRH) and stalling the HPA axis stress cascade. Simultaneously, it modulates serotonergic and dopaminergic output, generating deep anxiolytic effects and reinforcing empathetic neural circuitry.

CNTF C-terminal fragment. Preclinical neurotrophic and hypothalamic energy papers. Not FGL.

Operating precisely within the Islets of Langerhans, Pancragen penetrates the remaining viable pancreatic beta-cells. Binding to targeted DNA promoter regions, it forcefully reactivates genetic pathways that have been crushed by chronic high blood sugar. This epigenetic jolt drastically surges the localized synthesis of endogenous insulin and massively upregulates glucose transporter (GLUT) expression, physically increasing the cell's capacity to process glucose while halting apoptotic beta-cell death.

The active MGF sequence completely bypasses the traditional IGF-1 receptor pathway utilized for mature cell hypertrophy. Instead, it acts as a hyper-specific proliferative signal, binding directly to an uncharacterized MGF receptor on dormant muscle satellite (stem) cells residing just outside the muscle fiber. This interaction violently awakens the satellite cells - forcing rapid, exponential cellular division and proliferation. The PEGylation ensures this proliferative signal remains active systemically for over 72 hours.

Same BPC-157 sequence (GEPPPGKPADDAGLV). Arginate vs acetate changes formulation and possibly oral handling, not a new receptor target. Published animal literature is almost entirely the acetate/free peptide.

Amylin-pathway satiety agonist designed for infrequent injection under sponsor protocols. Separate from GLP-1-only and dual GIP/GLP-1 programs.

Blend: peptide fraction plus carotenoid antioxidants. Do not launder AREDS or Retinalamin data onto this SKU.

Designed as an HDM-2-binding p53 fragment plus a membrane peptide. In published cell work it colocalizes with membrane HDM-2 on transformed cells and induces necrosis independent of nuclear p53. That is laboratory oncology, not a labeled therapy.

Short cytogen peptides are claimed to act as gene-expression signals in the source-organ model. Human evidence is the Khavinson literature, not an FDA program. Do not confuse the tetrapeptide with the tissue extract.

Cyclic analog of MT-2 trimmed toward MC3/MC4. Hypothalamic melanocortin signaling, not nitric-oxide cavernosal plumbing. Non-selective enough that flushing and nausea still show up. Not Viagra.

Functions as a tri-agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously. While GLP-1 and GIP pathways synergize to crush appetite, delay empty rates, and optimize insulin sensitivity, the addition of glucagon receptor agonism acts as a metabolic furnace. It aggressively drives mitochondrial lipid oxidation (fat burning), enhances hepatic lipid clearance, and elevates the basal metabolic rate, completely negating the metabolic slowdown normally associated with severe caloric reservoirs.

Tuftsin analog. Russian clinical use is anxiolytic/nootropic. Parent t½ is minutes; nasal delivery is the usual route. Not a benzodiazepine.

Structurally engineered with a fatty acid diacid chain to prevent rapid degradation by the DPP-4 enzyme, achieving a 168-hour half-life. It agonizes GLP-1 receptors in the pancreatic beta cells to stimulate glucose-dependent insulin secretion while forcefully suppressing hepatic glucagon release. Centrally, it crosses the blood-brain barrier to bind hypothalamic receptors, dramatically delaying gastric emptying and nullifying pathological food-seeking behavior.

Functions as a highly specific agonist at the GHRH receptor located on the anterior pituitary gland. Being a truncated 29-amino-acid fragment of the endogenous 44-amino-acid GHRH molecule, it contains the exact functional core required for receptor activation. Its activation triggers an intracellular cAMP cascade within somatotrophs, provoking the synthesis and release of endogenous GH. Crucially, Sermorelin respects the body's somatostatin negative-feedback loop, making tachyphylaxis (receptor burnout) or dangerously high GH levels a physiological impossibility.

Operating downstream of leptin, Setmelanotide acts as a highly specialized molecular key designed to perfectly activate the Melanocortin-4 Receptor (MC4R) located in the hypothalamus. Unlike crude, dirty melanocortins like MT-2 that bleed onto MC1R (causing extreme tanning) or MC3R, Setmelanotide surgically hits only MC4R. This restores the critical leptin-melanocortin satiety cascade, successfully forcing the brain to register fullness.

Sigumir exerts absolute epigenetic control over the musculoskeletal system. Delivering organ-specific instructions to dormant osteoblasts and chondrocytes, it forcefully penetrates the cell nucleus. This triggers a massive, sudden un-silencing of the genes directly responsible for synthesizing Type II collagen, dense proteoglycans, and raw bone mineralization proteins. The result is the forced, accelerated biological reconstruction of the physical articular surface and internal bone density.

Snap-8 functions as a massively upgraded SNARE complex inhibitor. With its extended 8-residue sequence, it exerts a far superior, tighter lock on the SNAP-25/syntaxin interface. This intense steric hindrance results in an exceptional reduction of excitatory acetylcholine release at the neuromuscular junction, forcing a much deeper, profound paralysis of the superficial fascial musculature and drastically smoothing overlying epidermal tension.

Szeto tetrapeptide that associates with cardiolipin on the inner mitochondrial membrane. Cristae / ETC stability is the published frame. Antioxidant marketing is downstream of that, not a vitamin.

Operating precisely within the stomach lining, Stamakort delivers targeted peptide fractions into the nuclei of struggling parietal and chief cells. By binding to dormant regulatory DNA sequences, it acts as a permanent epigenetic reset. It heavily upregulates the synthesis of protective mucins and simultaneously recalibrates the genes responsible for producing hydrochloric acid (HCl) and pepsinogen, resulting in a physically robust, fully functional gastric environment.

Acyl GLP-1/glucagon dual agonist. Obesity and MASH programs are not a consumer reconstitution hobby.

Claimed to antagonize the muscle nicotinic receptor in a cosmetic model inspired by Temple viper waglerin. That is a marketing mechanism with in vitro support - not a prescription neuromodulator.

As a true agonist, Tabimorelin forcibly binds to GHS-R1a receptors localized heavily on both anterior pituitary somatotrophs and upstream hypothalamic GHRH neurons. It flawlessly mimics native Ghrelin, driving a massive, dose-dependent dumping of endogenous Growth Hormone. Crucially, it completely preserves the body’s natural, healthy pulsatile GH waveform - preventing the extreme receptor downregulation and insulin resistance routinely caused by synthetic recombinant GH injections.

The LKKTETQ motif is the actin-binding loop of thymosin β4 (Crockford 2010). The fragment is small and is given SubQ anywhere; that is not the same as proven systemic repair. Do not launder full-length Tβ4 cardiac or ophthalmic trials onto this vial.

Tesamorelin is a stabilized 44-aa GHRH analog (trans-3-hexenoic N-terminus) with documented visceral-fat reduction on label. Ipamorelin adds GHS-R1a drive. The combination is compounding/community practice, not an FDA-approved product.

Functioning entirely isolated from the HPTA negative feedback loop, Testagen slips past the blood-testis barrier to penetrate the nuclei of aging Leydig and Sertoli cells. Acting as a ruthless transcription factor, it aggressively un-silences the specific promoter regions controlling the StAR protein and complex steroidogenic enzymes (like CYP11A1). This violent genetic reactivation forces the testes to exponentially ramp up cholesterol conversion directly into raw, endogenous testosterone.

Functioning as a highly targeted agonist, Tetracosactide violently slams into Melanocortin-2 Receptors (MC2R) located exclusively on the adrenal cortex. This triggers an immediate, overwhelming adenylyl cyclase/cAMP cascade that forces cholesterol straight into the steroidogenic pathway. A single 250mcg dose clinically forces the adrenal glands to achieve maximum, absolute peak serum cortisol output within exactly 30 to 60 minutes.

As a perfectly isolated dipeptide, Thymogen slips immediately into target lymphocytes to exert profound epigenetic influence. It bypasses upstream signaling to directly stimulate the de novo synthesis of endogenous thymic hormones. It forces a massive upregulation in the surface expression of critical T-cell differentiation markers (CD3, CD4, CD8) and acts as an absolute governor of the immune response, forcefully dragging severe pathological Th2/Th1 cytokine imbalances back into perfect equilibrium.

Tα1 functions as a master pleiotropic regulator. It strongly agonizes Toll-Like Receptors (specifically TLR9) in dendritic cells, radically accelerating their maturation and antigen-presenting capabilities. It drives naive T-cells to rapidly differentiate into formidable CD4+ and CD8+ effector cells, supercharging natural killer (NK) cell cytotoxicity. Simultaneously, it actively suppresses IL-4 and IL-10 (Th2 cytokines) while dramatically upregulating Th1 cytokines like IFN-γ and IL-2, effectively weaponizing the immune system against intracellular pathogens and tumor cells.

Thymulin acts as a profound immunological signaling molecule, but it is biologically inert until it binds to an essential Zinc ion (Zn-thymulin complex). Once active, it binds to high-affinity receptors on immature T-lymphocytes, acting as a massive transcription factor. It aggressively forces the differentiation of raw thymocytes into elite CD4+ and CD8+ effector cells, while simultaneously shifting systemic cytokine production from inflammatory Th2 dominance back to a heavily defensive, anti-viral Th1 profile.

Operates as a highly targeted dual-agonist, binding to both Glucose-Dependent Insulinotropic Polypeptide (GIP) and GLP-1 receptors. The GIP agonism provides an additive effect by maximizing insulin sensitivity, augmenting white adipose tissue lipolysis, and fundamentally dampening the nausea profiles typically associated with GLP-1 activation. This simultaneous receptor cascade yields superior suppression of hepatic glucose production, unprecedented energy expenditure shifts, and prolonged central satiety signaling.

Promotes clearance of damaged mitochondria via mitophagy pathways in cell and human supplement studies. Identity is a small-molecule metabolite, not an amino-acid drug.

Unlike catecholamines (epinephrine), Vasopressin operates totally independent of adrenergic receptors. It violently agonizes V1a receptors on vascular smooth muscle, causing an immediate, profound, and sheer mechanical vasoconstriction of the splanchnic and systemic arterial beds. Simultaneously, it activates V2 renal receptors to ruthlessly reclaim free water, rapidly expanding blood plasma volume and forcibly hauling systemic blood pressure back from lethal hypotensive failure.

Short cytogen peptides in the Khavinson model are tissue-identity signals, here aimed at bladder wall / urothelium rather than nephron. Human evidence is the organ-map literature, not an FDA overactive-bladder program.

Because it is a mere dipeptide, Vilon's extremely low molecular weight allows it to bypass cellular defense barriers and penetrate directly into the nucleus of dormant thymocytes. Acting as a sequence-specific epigenetic key, it physically binds to the DNA histone matrix at the promotor regions governing immune function. This binding catastrophically un-silences dormant genes, instantly upregulating massive de novo synthesis of thymic hormones (like thymulin) and forcing explosive CD4+ and CD8+ T-lymphocyte maturation.

Visoluten’s highly specific nucleoproteins bypass systemic filtration to penetrate the nuclei of the retina, Retinal Pigment Epithelium (RPE), and optic ganglion cells. By exerting massive epigenetic influence, it forces the un-silencing of genes governing rhodopsin (visual pigment) repair, fiercely upregulates localized cellular antioxidant defenses against blue-light and UV oxidation, and aggressively prevents apoptosis within the critical optic nerve fibers.

Carrying the exact epigenetic blueprint of the juvenile immune system, Vladonix infiltrates the dormant thymic stroma. It acts as an absolute master epigenetic switch, forcing massive gene transcription necessary for raw thymocyte proliferation. This induces an exponential surge in the maturation, differentiation, and deployment of elite CD4+ (Helper) and CD8+ (Cytotoxic) T-cells, fundamentally rebuilding the body’s adaptive immunological hardware.

BPC-157 is a gastric pentadecapeptide studied for VEGF/NO-linked repair in animal models. TB-500 is a thymosin β-4 fragment that sequesters G-actin and is studied for cell migration. The stack is community-defined, not a single INN.

Delivering targeted nucleoproteins past the blood-follicle barrier, Zhenoluten penetrates the nuclei of aging granulosa and theca cells. By seizing epigenetic control over dormant DNA regions, it forces a massive, natural upregulation in the synthesis pathways for both estrogen and progesterone. Furthermore, it physically reactivates the complex genetic signaling cascades required for robust, healthy follicular maturation.